ICON taps Anthropic and Microsoft as it puts clinical-trial agents into production
Clinical trials are among the pharma domains seeing the most rapid embrace of AI agents, thanks to their potential extensibility and ability to automate routine tasks. Cost and complexity have a lot to do with that interest.